Biotech boom ahead in 2024, top Jefferies analyst predicts on heels of Bristol Meyers-Karuna deal Published 2023-12-22 Download video MP4 360p Download video MP4 720p Recommendations 06:39 Fundstrat's Tom Lee: Inflation is going to 'cool pretty dramatically' in the second half of 2024 07:09 Under-the-radar biotech bets 09:36 Warren Buffett explains why Berkshire reduced its big Apple stake 12:18 Why Widespread Tech Layoffs Keep Happening Despite A Strong U.S. Economy 07:35 WSJ's Greg Ip: Everybody's conviction of 2% inflation has to be lower after what we've seen 03:21 Earnings growth will carry more weight than valuation in 2024, says Edward Jones' Mona Mahajan 2:55:07 Berkshire's 2024 annual shareholder meeting: Watch the full morning session 03:34 Pharma could see a wave of M&A activity in 2024, says Jefferies' Michael Yee 01:42 Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash 06:49 Key takeaways on the markets and economy from Berkshire's annual meeting 02:54 Backdrop for stocks is still strong thanks to earnings, says Gunjan Banerji 10:33 😭 ЗНИЩЕНО ВСЮ ВУЛИЦЮ! ЧИМ ВДАРИЛА росія по Харківщині? 06:40 Taxes will have to go up eventually to tackle the deficit, says Wolfe Research's Tobin Marcus 4:52:00 Watch Warren Buffett preside over the full 2024 Berkshire Hathaway annual shareholders meeting 03:55 The AI party has already begun, says Wedbush Securities' Dan Ives 05:44 Інавгурації Путіна ОГОЛОСИЛИ БОЙКОТ. Хто НЕ ПРИЇДЕ на свято кремлівського диктатора? 09:32 Israeli leaders aren't terribly concerned with the public perception of Israel right now: Dan Senor 07:56 Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better Similar videos 04:49 Takara Bio Stock: Basic Analysis More results